Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, explains that the scientific community’s response to the COVID-19 pandemic has demonstrated the importance of international collaboration and harmonization, and highlights this as a key learning opportunity for the field of advanced therapies. Exciting technological advances and the emergence of organizations that support the industry and offer the ability to connect all stakeholders, including manufacturers, academics and patients, are expected to help to drive standardization and industrialization within the field, and ultimately, improve patient access to novel therapies in the future. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.